← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Epiodyne, Inc.
San Francisco, CA
$13,405,194
Total funding
4
Grants
Funding over time
peak $6.5M · FY2018–23$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$13,405,194 · 4
By mechanism
UG3$6,461,202 · 1
UH3$4,143,992 · 1
R44$2,500,000 · 1
R43$300,000 · 1
Investigators at Epiodyne, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Novel Therapeutics for Opioid Use Disorder in the Acute Overdose and Maintenance Settings$6,461,202
UG3 · FY2019 · DA
Novel Therapeutics for Opioid Use Disorder in the Acute Overdose and Maintenance Settings$2,594,546
UH3 · FY2022 · DA
Novel Therapeutics for Opioid Use Disorder in the Acute Overdose and Maintenance Settings$1,549,446
UH3 · FY2023 · DA
Development of an oral analgesic with reduced liabilities$1,488,866
R44 · FY2023 · DA
Development of an oral analgesic with reduced liabilities$1,011,134
R44 · FY2022 · DA
Structure-based Optimization of Novel Analgesics without Reinforcing Liabilities$300,000
R43 · FY2018 · DA